Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Björn Wängler is active.

Publication


Featured researches published by Björn Wängler.


European Journal of Nuclear Medicine and Molecular Imaging | 2008

Tetrafluorophenolate of HBED-CC: A versatile conjugation agent for 68Ga-labeled small recombinant antibodies

Matthias Eder; Björn Wängler; Stefan Knackmuss; Fabrice LeGall; Melvyn Little; Uwe Haberkorn; Walter Mier; Michael Eisenhut

PurposeThe success of 68Ga-labeled peptides for positron emission tomography of neuroendocrine tumors is mainly depending on the complex chemistry of this radioisotope. 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), the chelator of choice has however limitations if its application is expanded to heat-sensitive proteins. Recombinant antibodies like single chain Fv or diabodies belong to this class of proteins. They are suited to provide imaging contrast despite the short-lived 68Ga because of their rapid blood clearances and nanomolar affinities. The heterobifunctional agent N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N′-diacetic acid (HBED-CC) was chosen as an alternative ligand because this agent is complexing [68Ga]Ga3+ much faster than DOTA at ambient temperatures.Materials and methodsA versatile technology for HBED-CC conjugation of proteins and 68Ga-labeling has been developed. This included HBED-CC–tetrafluorophenol (TFP) ester synthesis, coupling to the antibody at various pH and complexation reactions performed in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer under different conditions.ResultsThe synthesis of the monoreactive 2,3,5,6-tetrafluorophenolate of HBED-CC at a carboxyl group not participating in complex formation used [Fe(HBED-CC)]− for ester formation. The removal of Fe3+ from purified (HBED-CC)TFP ester was achieved with RP18 cartridge technology. The conjugation chemistry was performed with mAb425 which binds to the epidermal growth factor receptor (EGFR). This protein was used for optimizing purposes only. The influence of complexation parameters like temperature, pH, reaction time, and HBED-CC/antibody ratio on the biological activity of this model antibody was investigated. Furthermore, the outcome of this labeling procedure on the biological activity of a recombinant diabody (50xa0kDa) was studied.ConclusionIt is known that small HBED-CC/antibody ratios are prerequisites for minimal interference of labels with antigen-binding domains. Here, the coupling of about one HBED-CC per antibody proved to be sufficient for efficient 68Ga labeling, pointing to the successful application of 68Ga for molecular imaging with small recombinant proteins.


Langmuir | 2007

Silica- and Alkoxysilane-Coated Ultrasmall Superparamagnetic Iron Oxide Particles: A Promising Tool To Label Cells for Magnetic Resonance Imaging

Chunfu Zhang; Björn Wängler; Bernd Morgenstern; Hanswalter Zentgraf; Michael Eisenhut; Harald Untenecker; Ralf Krüger; Ralf Huss; Christian Seliger; Wolfhard Semmler; Fabian Kiessling


Bioorganic & Medicinal Chemistry | 2008

Improved syntheses and applicability of different DOTA building blocks for multiply derivatized scaffolds

C. Wängler; Björn Wängler; Michael Eisenhut; Uwe Haberkorn; Walter Mier


Tetrahedron Letters | 2006

Application of tris-allyl-DOTA in the preparation of DOTA-peptide conjugates

Björn Wängler; Carmen Beck; Ulrike Wagner-Utermann; Esther Schirrmacher; Claudia Bauer; Frank Rösch; Ralf Schirrmacher; Michael Eisenhut


Faculty of Health; School of Psychology & Counselling | 2012

Compensation for Cranial Spill-In Into the Cerebellum Improves Quantitation of Striatal Dopamine D 2/3 Receptors in Rats With Prolonged ( 18 F)-DMFP Infusions

Erik Mille; Paul Cumming; Axel Rominger; Christian la Fougère; Klaus Tatsch; Björn Wängler; Peter Bartenstein; Guido Böning


Archive | 2007

Upar selective contrast agent for magnetic resonance imaging

Manfred Jugold; Fabian Kiessling; Chunfu Zhang; Björn Wängler; Rüdiger Pipkorn; Wohlfhard Semmler


Society of Nuclear Medicine Annual Meeting Abstracts | 2010

Alpha2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse

Axel Rominger; Björn Wängler; Peter Bartenstein; Paul Cumming


Archive | 2019

Silicon-based 18F-radiopharmaceuticals

Ralf Schirrmacher; Vadim Bernard-Gauthier; Esther Schirrmacher; Justin J. Bailey; Klaus Jurkschat; Carmen Wängler; Björn Wängler


Archive | 2017

Bioorthogonal Coupling Strategies Used in Pretargeted Nuclear Imaging and Radiotherapy

Justin J. Bailey; Carmen Wängler; Björn Wängler; Ralf Schirrmacher


Archive | 2014

Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride

Carmen Wängler; Petia Djurova; Björn Wängler; Gert Fricker

Collaboration


Dive into the Björn Wängler's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Eisenhut

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Uwe Haberkorn

University Hospital Heidelberg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ljuba Iovkova

Technical University of Dortmund

View shared research outputs
Researchain Logo
Decentralizing Knowledge